News & Press Releases

Sige Gutman was quoted in Endpoints News about SCOTUS’ unanimous decision siding with Hikma in a closely watched “skinny label” case and its implications for generic drugmakers.

Sige Gutman was quoted in STAT about SCOTUS’ unanimous decision backing a generic drugmaker in a key “skinny labeling” case that is expected to support continued generic competition.

Mintz is advising the placement agents in connection with the $215 million private placement that is expected to close concurrently with the completion of the merger transaction between Avenzo Therapeutics, Inc. and Rallybio Corporation.

Mintz’s Intellectual Property Practice earned national recognition in the 2026 edition of IAM Patent 1000: The World’s Leading Patent Practitioners. The guide recognizes Mintz with four firmwide rankings and 17 individual attorney distinctions, including a gold ranking for Michael Renaud, who leads the firm’s IP Division.

Mintz Member Terri Shieh-Newton, PhD, has been named to Forbes’ inaugural 2026 America’s Top Women Lawyers list. The list recognizes women in private practice who have built elite reputations through high-stakes legal work, client impact, and leadership across the profession.

Mintz advised the underwriters in connection with NervGen Pharma’s $60 million public offering of common shares and accompanying warrants.